Research news
Date
Summary
UK researchers have shared promising results of a phase 2 clinical trial of the type 2 diabetes drug exenatide in people with Parkinson's.
Date
Summary
New research, reported in the scientific journal Nature, suggests that the immune system plays an important role in the progression of Parkinson's.
Date
Summary
Higher consumption of low fat dairy products such as milk, butter, cheese and yoghurt is linked to a modest increase in risk of Parkinson’s, according to new research.
Date
Summary
Scientists have developed a new technique that shows promise as a non-invasive approach to deep brain stimulation.
Date
Summary
The groundbreaking clinical trial of GDNF, a potential treatment for Parkinson's, is now complete. Analysis of the results is now well underway and is expected to be published in the summer.
Date
Summary
New research shows promise for repurposed drugs that slow dementia.
Date
Summary
New research published in Nature Biotechnology shows that it may be possible to reprogramme cells inside the brain to reverse the symptoms of Parkinson's.
Date
Summary
Research suggests there may be a link between hepatitis infection and an increased risk of developing Parkinson's.
Date
Summary
We’re excited to announce that Professor David Dexter has joined us as our new Deputy Director of Research.
Date
Summary
Parkinson's UK and the University of Sheffield have launched a new £1million virtual biotech company, Keapstone Therapeutics, to combine world-leading research from the University with funding and expertise from the charity to develop new treatments.